Detalles de la búsqueda
1.
Significance of additional high-dose cytarabine in combination with cyclophosphamide plus total body irradiation regimen for allogeneic stem cell transplantation.
Bone Marrow Transplant;
39(1): 25-30, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17115063
2.
Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation.
Bone Marrow Transplant;
37(3): 289-96, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16400341
3.
Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease.
Bone Marrow Transplant;
36(10): 867-72, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16113659
4.
Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study.
Leukemia;
16(7): 1259-66, 2002 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12094249
5.
Gamma-interferon production capacity and T lymphocyte subpopulation after allogeneic bone marrow transplantation.
Transplantation;
41(3): 311-5, 1986 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-3082047
6.
Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement.
Bone Marrow Transplant;
11(4): 255-9, 1993 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-7683550
7.
Epstein-Barr virus-negative high grade B cell lymphoma of donor origin developing 19 months after unrelated allogeneic bone marrow transplantation.
Bone Marrow Transplant;
26(5): 577-9, 2000 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-11019851
8.
Treatment of adult T cell leukemia with mega-dose cyclophosphamide and total body irradiation followed by allogeneic bone marrow transplantation.
Bone Marrow Transplant;
2(4): 441-4, 1987 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-3332192
9.
Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant;
27(1): 15-20, 2001 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-11244433
10.
Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia.
Bone Marrow Transplant;
24(9): 995-1003, 1999 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-10556959
11.
Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant;
32(8): 801-7, 2003 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-14520425
12.
Molecular remission achieved by interferon therapy in a patient with cytogenetically relapsed chronic myelogenous leukemia after syngeneic bone marrow transplantation.
Int J Hematol;
64(3-4): 267-70, 1996 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-8923790
13.
Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors.
Int J Hematol;
70(2): 119-26, 1999 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-10497851
14.
Allogenic bone marrow transplantation as a treatment for adult T-cell leukemia.
Int J Hematol;
69(3): 203-5, 1999 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-10222661
15.
A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
Int J Hematol;
69(1): 27-35, 1999 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-10641440
16.
Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
Int J Hematol;
72(2): 229-36, 2000 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-11039674
17.
Posttreatment nadir M-protein level is a stronger discriminator of survival following plateau attainment than is percent reduction in M-protein in patients with IgG myeloma.
Int J Hematol;
74(2): 205-8, 2001 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-11594523
18.
Effective and safe interferon treatment for Japanese patients with chronic myelogenous leukemia relapse after bone marrow transplantation. The Nagoya Blood and Marrow Transplantation Group.
Int J Hematol;
72(2): 237-42, 2000 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-11039675
19.
Quality of life in adult patients after stem cell transplantation.
Int J Hematol;
71(3): 283-9, 2000 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-10846837
20.
Serum thrombopoietin level after allogeneic bone marrow transplantation: possible correlations with platelet recovery, acute graft-versus-host disease and hepatic veno-occlusive disease. Nagoya Bone Marrow Transplantation Group.
Int J Hematol;
64(3-4): 241-8, 1996 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-8923786